Be up to date with the 2024 AMH Book or Online
We are constantly improving and updating the AMH; here are some recent changes that may interest you:
- new drugs, eg finerenone for chronic kidney disease (including potentially clinically important interactions)
- new indications for Janus kinase inhibitors, eg tofacitinib for juvenile idiopathic arthritis, baricitinib for alopecia areata and upadacitinib for Crohn’s disease
- revised therapeutic information, eg for the management of migraine
- new adverse effects for old drugs, eg myasthenia gravis with statins, acute coronary vasospasm with amoxicillin and with cefuroxime
- discontinued products, eg live zoster vaccine, and related information removed
Many new anticancer drugs have also been added; there is a summary of key changes, including all new and deleted drugs, in every edition.
If you’re new to AMH, make sure you watch our videos.
AMH Children’s Dosing Companion - January 2024 Online release
The January 2024 release of the AMH Children’s Dosing Companion is available now. Changes include 5 new monographs. Specific changes of interest include:
- dosing information for the second SGLT2 inhibitor for type 2 diabetes, empagliflozin, in children 10 years and older
- dosing for sacubitril with valsartan for paediatric heart failure
- two new monographs for drugs used in pulmonary arterial hypertension, tadalafil and riociguat
- doses for cystic fibrosis drugs are included down to ages as young as 6 months.
Many small but important changes are made in every update of the CDC; these are outlined in the Summary of key changes. You should make checking this summary one of the first things you do with every new release.
AMH Aged Care Companion - April 2023 Online Release
The AMH Aged Care Companion is our trusted, practical reference for health care professionals who work with older people.
The selected topics included in this companion reflect some of the most common illnesses and problems requiring drug treatment that confront the aged.
With every update, there are many changes to ensure the information remains current and relevant to the use of medicines in older people.
This release has new content and a number of changes. Updated topics that may be of interest include benign prostatic hyperplasia, constipation, dyspepsia, fall prevention, heart failure, hypertension, oedema, osteoarthritis, peripheral arterial disease, prostatitis, stroke prevention and urinary tract infection.
Many small but important changes are made in every update of the ACC; these are outlined in the Summary of key changes. You should make checking this summary one of the first things you do with every new release.
Beware - buying electronic AMH products from other sources
Electronic versions of all AMH products are ONLY available for purchase from the AMH website. Any other website advertising the sale of AMH products may contain malicious software that may harm the integrity of your computer.
Likewise, any unauthorised email offer on these products could be spam. If you are unsure of its content, please delete the email and report the incident to us via email@example.com
To buy AMH print products, please go to the support page of the AMH website and select AMH Stockists found under the heading Where to buy AMH products.